TRANSPHORM INC's ticker is TGAN and the CUSIP is 89386L100. A total of 40 filers reported holding TRANSPHORM INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,241,538 | -7.1% | 1,009,702 | +42.3% | 0.05% | +16.3% |
| Q2 2023 | $2,412,980 | -14.8% | 709,700 | 0.0% | 0.04% | 0.0% |
| Q1 2023 | $2,831,703 | -26.7% | 709,700 | 0.0% | 0.04% | -8.5% |
| Q4 2022 | $3,860,768 | +8.1% | 709,700 | 0.0% | 0.05% | +9.3% |
| Q3 2022 | $3,570,000 | +32.0% | 709,700 | 0.0% | 0.04% | +38.7% |
| Q2 2022 | $2,704,000 | -55.9% | 709,700 | -18.2% | 0.03% | -53.0% |
| Q1 2022 | $6,133,000 | – | 867,500 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 3,772,875 | $18,978,000 | 5.90% |
| Worth Venture Partners, LLC | 911,237 | $4,584,000 | 2.81% |
| Kohlberg Kravis Roberts & Co. L.P. | 22,675,980 | $114,060,000 | 2.29% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 250,944 | $1,262,000 | 1.37% |
| Soros Fund Management | 673,991 | $3,390,000 | 0.06% |
| Polar Asset Management Partners Inc. | 709,700 | $3,570,000 | 0.04% |
| AMERIPRISE FINANCIAL INC | 3,805,595 | $19,142,000 | 0.01% |
| Stratos Wealth Partners, LTD. | 30,000 | $151,000 | 0.00% |
| FMR LLC | 886 | $4,000 | 0.00% |
| AMERICAN INTERNATIONAL GROUP, INC. | 10,801 | $54,000 | 0.00% |